Literature DB >> 27723141

Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis.

Ya-Hui Chiu1, Edward Schwarz2, Dongge Li1, Yuexin Xu3, Tzong-Ren Sheu2, Jinbo Li4, Karen L de Mesy Bentley3,4, Changyong Feng5, Baoli Wang6, Jhih-Cheng Wang7, Liz Albertorio-Saez1, Ronald Wood8, Minsoo Kim3, Wensheng Wang9, Christopher T Ritchlin1.   

Abstract

DC-STAMP is a multi-pass transmembrane protein essential for cell-cell fusion between osteoclast precursors during osteoclast (OC) development. DC-STAMP-/- mice have mild osteopetrosis and form mononuclear cells with limited resorption capacity. The identification of an Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) on the cytoplasmic tail of DC-STAMP suggested a potential signaling function. The absence of a known DC-STAMP ligand, however, has hindered the elucidation of downstream signaling pathways. To address this problem, we engineered a light-activatable DC-STAMP chimeric molecule in which light exposure mimics ligand engagement that can be traced by downstream Ca2+ signaling. Deletion of the cytoplasmic ITIM resulted in a significant elevation in the amplitude and duration of intracellular Ca2+ flux. Decreased NFATc1 expression in DC-STAMP-/- cells was restored by DC-STAMP over-expression. Multiple biological phenotypes including cell-cell fusion, bone erosion, cell mobility, DC-STAMP cell surface distribution, and NFATc1 nuclear translocation were altered by deletion of the ITIM and adjacent amino acids. In contrast, mutations on each of the tyrosine residues surrounding the ITIM showed no effect on DC-STAMP function. Collectively, our results suggest that the ITIM on DC-STAMP is a functional motif that regulates osteoclast differentiation through the NFATc1/Ca2+ axis. J. Cell. Physiol. 232: 2538-2549, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27723141      PMCID: PMC5386838          DOI: 10.1002/jcp.25638

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  47 in total

1.  MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.

Authors:  Ce Dou; Chengcheng Zhang; Fei Kang; Xiaochao Yang; Hong Jiang; Yan Bai; Junyu Xiang; Jianzhong Xu; Shiwu Dong
Journal:  Biochim Biophys Acta       Date:  2014-08-11

2.  Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

3.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP.

Authors:  Rabia Islam; Han-Sol Bae; Won-Joon Yoon; Kyung-Mi Woo; Jeong-Hwa Baek; Hong-Hee Kim; Takafumi Uchida; Hyun-Mo Ryoo
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

5.  DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells.

Authors:  F C Hartgers; J L Vissers; M W Looman; C van Zoelen; C Huffine; C G Figdor; G J Adema
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

6.  Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.

Authors:  Koichi Matsuo; Deborah L Galson; Chen Zhao; Lan Peng; Catherine Laplace; Kent Z Q Wang; Marcus A Bachler; Hitoshi Amano; Hiroyuki Aburatani; Hiromichi Ishikawa; Erwin F Wagner
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

7.  RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.

Authors:  Susan Li; Christine H Miller; Eugenia Giannopoulou; Xiaoyu Hu; Lionel B Ivashkiv; Baohong Zhao
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 19.456

8.  Osteoclast fusion is based on heterogeneity between fusion partners.

Authors:  Anne-Sofie Hobolt-Pedersen; Jean-Marie Delaissé; Kent Søe
Journal:  Calcif Tissue Int       Date:  2014-05-27       Impact factor: 4.333

9.  miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.

Authors:  Jing Y Krzeszinski; Wei Wei; HoangDinh Huynh; Zixue Jin; Xunde Wang; Tsung-Cheng Chang; Xian-Jin Xie; Lin He; Lingegowda S Mangala; Gabriel Lopez-Berestein; Anil K Sood; Joshua T Mendell; Yihong Wan
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

10.  CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis.

Authors:  Yahui Grace Chiu; Tianmeng Shao; Changyong Feng; Kofi A Mensah; Michael Thullen; Edward M Schwarz; Christopher T Ritchlin
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

View more
  15 in total

1.  Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.

Authors:  Emilie Laurier; Nathalie Amiable; Edith Gagnon; Jacques P Brown; Laëtitia Michou
Journal:  BMC Med Genet       Date:  2017-11-16       Impact factor: 2.103

2.  Targeted sequencing of DCSTAMP in familial Paget's disease of bone.

Authors:  M A Sultana; N J Pavlos; Lynley Ward; J P Walsh; S L Rea
Journal:  Bone Rep       Date:  2019-02-21

3.  Tea extract increases cell fusion via regulation of cell surface DC-STAMP.

Authors:  Kenji Kuriya; Masahiro Nishio; Tomoko Matsuda; Hayato Umekawa
Journal:  Biochem Biophys Rep       Date:  2020-05-11

4.  Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway.

Authors:  Hyung Joon Kim; Hwa-Sik Seong; YunJeong Choi; Soon Chul Heo; Yong-Deok Kim
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

5.  Osteoclasts Differentiation from Murine RAW 264.7 Cells Stimulated by RANKL: Timing and Behavior.

Authors:  Nadia Lampiasi; Roberta Russo; Igor Kireev; Olga Strelkova; Oxana Zhironkina; Francesca Zito
Journal:  Biology (Basel)       Date:  2021-02-04

6.  Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.

Authors:  Bin-Hua Zou; Yan-Hui Tan; Wen-de Deng; Jie-Huang Zheng; Qin Yang; Min-Hong Ke; Zong-Bao Ding; Xiao-Juan Li
Journal:  Acta Pharmacol Sin       Date:  2020-08-04       Impact factor: 6.150

Review 7.  The role of dendritic cells derived osteoclasts in bone destruction diseases.

Authors:  Bo Wang; Yutong Dong; Zhansong Tian; Yueqi Chen; Shiwu Dong
Journal:  Genes Dis       Date:  2020-04-07

Review 8.  Osteoclast Multinucleation: Review of Current Literature.

Authors:  Joe Kodama; Takashi Kaito
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

9.  PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption.

Authors:  Eunjin Cho; Zhihao Chen; Jinkyung Lee; Sunwoo Lee; Tae-Hoon Lee
Journal:  Molecules       Date:  2019-09-14       Impact factor: 4.411

10.  Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss.

Authors:  Xiaochen Sun; Chenxi Zhang; Huan Guo; Jiao Chen; Yali Tao; Fuxiao Wang; Xixi Lin; Qian Liu; Li Su; An Qin
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.